Skip to main content

Autoimmune Encephalitis clinical trials at UCSF

1 research study open to eligible people

Autoimmune encephalitis is a condition where the immune system mistakenly attacks the brain. UCSF is conducting a study to understand the effects of Satralizumab on patients with NMDAR or LGI1 encephalitis. We are evaluating its safety, how it works, and how it travels within the body.

Showing trials for

Last updated: